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Summary
We have taken advantage of some unique properties of H-2Ld to investigate the determinant
density requirements for cytotoxic T lymphocyte (CTL) priming versus effector function and
to correlate the determinant density requirements with CD8 dependency. In a previous study
(Lie, W.-R., N. B. Myers, J. Gorka, R. J. Rubocki, J. M. Connolly, and T H. Hansen. 1990.
Nature (Loud.]. 344:439), we demonstrated that culturing normal cells with peptides known to
be restrictedby H-2Ld led to a two- to fourfold increase in surface Ld expression. In the present
study, we demonstrate the generation of Ld-restricted, peptide-specific in vitro primary CTL
by culturing spleen- cells with murine cytomegalovirus or turn - peptide at concentrations
previously shown to result in maximum induction of Ld expression. Target cells can be sensitized
for recognition by these CTL with lower doses of peptide than are required for the primary
sensitization. This demonstrates differences in the determinant density requirements for priming
versus effector function. The in vitro primary CTL generated with peptide can weakly lyse target
cells that express the determinant endogenously, and CTL lines and clones capable of strong
lysis ofendogenous expressors are easily obtained. In both cases, target cells treated with exogenous
peptide are lysed better than target cells expressing antigen endogenously. This suggested that
there are differences in the determinant density of peptide-fed versus endogenous targets. This
interpretation was substantiated when it was observed that the level oflysis of target cells expressing
endogenous determinants correlated inversely with the amount of peptide required to sensitize
targets for recognition by various turn--specific CTL clones. Furthermore, simultaneous titration
of both the peptide used to treat target cells and the antibody to CD8 revealed that the various
CTL clones analyzed displayed widely disparate CD8 dependencies. In each case, the CD8 de-
pendency correlatedinverselywith the determinant density requirement. Therefore, CD8 dependency
of CTL is relative, but shows an absolute and quantitative correlation with their dependency
on determinant density. These findings suggest that under physiologic conditions, where only
low determinant densities are likely to be encountered, all CTL clones will show at least partial
CD8 dependency.
C
TL responses restricted by MHC class I molecules in-
volve recognition of processed antigenic peptides con-
tained within a groove formed by the ct helices of the two
N142-terminal domains of the MHC glycoprotein (1). Al-
though short synthetic peptides have been shown to serve
as target antigen for CTL primed with whole virus (2, 3),
peptide fragments (4, 5), or xenoantigen (6), peptide alone
could not easily prime specific CTL in vivo (4) or in vitro
(7). This in vitro defect was overcome at high cell density,
but the resulting CTL were in some cases MHC crossreac-
tive and none were capable of lysing target cells expressing
endogenous determinants (7). In vivo priming with peptide
has been achieved only by chemical modification of the pep-
tides (8, 9). A possible explanation for the inability to prime
with peptide is that a higher density ofantigenic determinants
is required for priming and this is difficult to achieve with
peptide alone. We were able to test this hypothesis by taking
advantage of a unique feature of H-2Ld. We recently demon-
strated that culturing normal cells with peptides known to
be restricted by H-2Ld led to a dramatic increase in the ex-
pression of Ld, suggesting that from 60% to 75% of the
surface Ld molecules contained the fed peptide (10). We
therefore reasoned that peptide-fed cellswould express suffi-
cient antigenic determinants to serve as stimulators for CTL.
Another attractive feature of this system is that the Ld-
restricted peptides selected for this analysis have been well
characterized by others as CTL recognition determinants. One
of the peptides is derived from the murine cytomegalovirus
(MCMV)t immediate early protein (iel) and has been shown
'Abbreviations used in thispaper: MCMV, murine cytomegalovirus; RCAS,
rat Con A supernatant.
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genic determinant recognized by Ld-restricted CTL from
MCMVimmune mice. The other peptide (turn - ) is derived
from a mutant tumor cell line and has been shown by Boon
and associates (13) to contain the only antigenic determinant
recognized by Ld-restricted CTL from mice immunized
with the mutant tumor cell, P91A. Cell lines endogenously
expressing the determinants defined by the MCMV, and
turn - peptides were made available to us by Drs. U. Kos-
zinowski (University of Ulm, FRG) and T. Boon (Ludwig
Institute for Cancer Research, Brussels, Belgium). Since in-
duction of Ld with peptide results in expression of a high
density of the Ld/peptide complex and these same peptides
at low concentrations have been shown to sensitize target
cells for recognition by CTL clones derived from animals im-
munized with virus or mutant cells (11, 13), it was possible
to analyze a broad rangeofdeterminant densities by titering
the peptide concentration.
In this study, we report the generation of Ld-restricted,
peptide-specific in vitro primary CTL using low numbers
ofpeptide-fed cells or peptide alone as immunogen and stan-
dard numbers of respondingcells. In contrast to earlier reports
(7-9), lysis was obtained on both peptide-fed targets and on
targets expressing endogenous determinants. In addition, we
have been able to maintain long-term, Ld-restricted, peptide-
specific CTL clones and lines using lower doses of peptide.
Clones were obtained that differed in their ability to lyse en-
dogenous expressors, in the amount of exogenous peptide
required to sensitize target cells and/or in the requirement
for CD8. The CTL clones were therefore used to assess the
determinant density requirement for target cell recognition
and to correlate determinant density with the requirement
for CD8. This report is the first demonstration of class I-re-
stricted, peptide-specific primary CTL induced in vitro that
are not crossreactive with other MHC haplotypes and that
can lyse target cells that express the antigenic determinant
endogenously. Furthermore, using this system, peptide-s
CTL clones were generated that possessed widely disparate
determinant density requirements, thus allowing us to quan-
titatively assess the relationship between determinant den-
sity and CD8 dependency.
Materials and Methods
Mice and Antibodies.
￿
BALB/c Kh (H-2d) mice were bred in the
animal facility of Dr. Donald C. Shreffler, Washington University
School of Medicine, St. Louis, MO. mAbs 30-5-7 and 28-14-8 are
both mouse IgG2a isotypes that have previously been shown to
react with the a1/at2 and a3 domains of H-2L', respectively (14,
15). mAb 53-6.72 is a rat IgG2 that reacts with CD8 of all mouse
strains (16). Culture supernatants ofthe mAbs were used for flow
cytometry analysis as described below. An ascites of 53-6.72, pro-
duced in nude mice, was used for blocking CTL function as de-
scribed below.
Peptides.
￿
The amino acid sequence of the MCMV peptide cor-
responds to residues 168-176 (YPHFMPTNL) of the MCMV
immediate early protein pp89 (11). The amino acid sequence of
the turn- peptide corresponds to residues 12-24 (ISTQNHRA-
LPLVA) of the mutant protein P91A- (exon 4) from the turn -
P815 variant (13).
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Peptides were synthesized using Merrifield's solidphase method
(17) on a peptide synthesizer (model 431A; Applied Biosystems,
Inc., [ABI], Foster City, CA). All peptide synthesis reagents were
of high purity (>99%) and supplied by ABI. The resin used for
peptide synthesis was phenylacetamidomethyl and was pre-loaded
with 0.5 mM of required amino acid. All amino acids used were
t-Boc protected at the NHz terminus, and theirreactive side chains
were protected with the standard groups recommended by ABI
for t-Boc synthesis, with the exception of histidine. The histidine
derivative used was N-tx-Boc-N-w-Benzyloxymethyl-L-histidine sup-
plied by Bachem Inc. (Torrance, CA). The Boc amino acids were
coupled using carbodiimide-hydroxybenzotriazole coupling cycles
as recommended by the manufacturer. The peptides were simul-
taneously deprotected and cleaved from the resin by treatment
with anhydrous hydrogen fluoride/anisole/dimethyl sulfide 10:1:1
(vol/vol/vol) for 50 min at 0°C. The cleaved peptide was washed
with diethylether to remove organic byproducts generated during
HF cleavage. The peptide was then extracted from the resin with
30% acetic acid. The acetic acid was removed by rotary evapora-
tion, and the remaining aqueous peptide solution was diluted four-
fold with Hz0, shell frozen, and lyophilized. Peptides were
purified (>90%) by reverse phase HPLC and subjected to purity
assessment techniques as previously described (18).
Cell Lines and Peptide Induction.
￿
R1.1-Ld, R1.1-Dd, R1.1-L9,
and RI.1-D9 were generated by introducing the Ld, Dd, L9, and
D9 genes, respectively, into the Rl.l (H2k) thymoma cell line by
electroporation and selected in medium containing G418 antibi-
otic. P815 is an H-2d mouse mastocytoma cell line and P911 (from
Dr. T Boon)is a mutant cell line derived from P815 that expresses
the turn- antigen, P91A- (13). LLd was generated by introducing
the Ld gene into thymidine kinase-deficient mouse L cell fibro-
blasts (H-2k) by calcium phosphate coprecipitation. L/iel/Ld (from
Dr. U. Koszinowski) is a mouse L cell fibroblast transfected with
both the Ld gene and the gene encoding MCMV immediate early
protein pp89 (12). The cell lines were maintained in RPMI 1640
(Gibco Laboratories, Grand Island, NY) supplemented with peni-
cillin, streptomycin, glutamine, and 10% FCS (Hyclone Laborato-
ries, Logan, UT). For peptide induction, 5 x 105 cells/ml in
RPMI-FCS were cultured overnight (16-18 h) in the presence of
50-100 AM peptide. The cells were washed and used as stimulators,
targets, or analyzed by flow cytometry.
Flow Cytometry.
￿
For fluorescence analysis, cells were washed
and resuspended in HBSS lacking phenol red but containing 0.2%
BSA and 0.1% sodium azide. 4 x 105 cells/well were incubated
for 30 min at 4°C in the presence of a saturating concentration
ofmAb or medium alone in a 96-well plate. The cells were washed
and incubated in a saturating concentration of fluorescein-
conjugated, affinity-purified F(ab')2 fragment of goat anti-mouse
IgG, Fc-specific, or of goat anti-rat IgG (Cooper Biomedical, Inc.,
Malvern, PA) for 30 min at 4°C. The cells were then washed and
resuspended in medium containing 10 Ag/ml propidium iodide,
used to exclude dead cells from analysis.
Cells were analyzed on a FACS IV® (Becton Dickinson & Co.,
Mountain View, CA) equipped with an argon ion laser tuned to
488 nm and operating at 300 mW of power. Fluorescence histo-
grams were generated with logarithmic amplification of fluores-
cence emitted by single viable cells. Each sample analyzed com-
prised a minimum of 5 x 10^ cells. Cells labeled with only the
fluorescein-conjugated antibody were always included as controls.
Generation ofIn Vitro Primary Peptide-specific CTL.
￿
5 x 106 or
7.5 x 106 responding BALB/c spleen cells were cocultured with
105 stimulating peptide-fed P815 cells (10,000 rad) or with various
concentrations (10-5 to 10-4 M) of MCMV or turn- peptide in24-well Linbro trays (Flow Laboratories, ICN Biomedicals, Hor-
sham, PA)containing 2ml RPMI 1640 supplemented with L-glu-
tamine, sodium pyruvate, nonessential aminoacids, penicillin, strep-
tomycin, 5 x 10-5 M a-mercaptoethanol, and 10% FCS. After
5 d at 37°C in the presence of 5% C02, effector cells were har-
vested, washed, and resuspended in RPMI 1640 supplemented with
10% FCS (RPMI-FCS).
Generation ofPeptide-speck CTL Lines and Clones.
￿
CTL lines
were established from primarycultures by incubating primary CTL
for one additional week at 3 x 106/well in 2 ml of sensitization
medium containing various concentrations ofpeptide. Subsequently,
lines were maintained by weekly restimulation of 2 x 105
cells/well in the presence of 105 irradiated (2,000 rad) BALB/c
spleen cells and 0.3-1.2 x 10-5 M peptide in 2 ml sensitization
medium containing 10% rat Con Asupernatant (RCAS). In some
cases, clones were established from lines by limiting dilution. For
cloning directly from primarycultures, 40 ml at 5 x 106 cells/ml
were cultured in a 75-cm2 flask for 6 d in the presence of 10 -° M
peptide. The cellswere washed andplated in round-bottomed mi-
crotiter plates at five different cell concentrations in replicates of
96. In addition, thewells contained 106 irradiated BALB/c spleen
cells in 0.2 ml of sensitization medium containing RCAS and
10-5 M peptide. Theclones were restimulated weekly by replacing
100 /1 of medium with fresh medium containing 106 irradiated
BALB/c spleen cells, RCAS, and 10 -5 M peptide. After 3 wk, the
clones were tested in a "Cr release assay for activity against P815
with and without peptide. Positive wells were selected for expan-
sion based on the likelihood of clonality according to Poisson
statistics (19).Selected clones were maintained by weekly restimu-
lation in 24-well plates as described above.
"Cr Release Assay.
￿
106 target cells were labeled with 150-300
PCi of "Cr (Na"Cr04, 10-25 mCi/ml; Amersham Corp.,
Arlington Heights, IL) in 100 pl of RPMI-FCS with or without
peptide for 1 h at 37°C in 5% C02. In some experiments, cells
were cultured overnight with peptide before labeling. For experi-
ments in which the peptide concentration was titered, target cells
were pre-incubated with "Cr, and 2.5 x 105 labeled cells in
500 Al of RPMI-FCS were added to several different tubes with
the appropriate concentration of peptide. After 1 h, the cells were
washed twiceand 5 x 103 cells were added to the wells of round-
bottomed microtiter plates. For antibody blocking, 50 P.l of anti-
body was preincubated with 100 A1 of effector cells for 15 min at
37°C. 50 Al of target cells was added and the plates were spun
at 50 g for 1 min and incubated for 4 h at 37°C, 5% C02. 100 P,1
ofsupernatant wascountedin an ISOMEDIC gamma counter (ICN
Biomedicals). The mean of triplicate samples was calculated and
percent "Cr release was determined according to the following
equation: percent "Cr release = 100x [(experimental "Cr release
- control -"Cr release)/(maximum "Cr release - control "Cr
release)]; where experimental "Crrelease represents counts from
target cells mixed with effector cells, control "Cr release represents
counts from target cells incubated in medium alone (spontaneous
release), and maximum "Cr release represents counts from target
cells exposed to 5% Triton-X 100. For the data presented in this
paper, the SEM percent specific lysis was <5% of the value of the
mean.
Results
Generation of In Vitro Primary Ld-restricted Peptide-speck
CTL. To obtain maximum induction of Ld expression,
P815 cells were cultured overnight with 10-4 M MCMV
peptide (10), previously shown to use Ld as the restricting
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Figure 1. (A) MCMV peptide-specific primary CTL induced with
peptide-fed P815 or peptide alone. 7.5 x 106 responding BALB/c spleen
were cocultured for 5 d with 105 peptide-fed P815 (10,000 rad) or with
3 x 10-5 M MCMV peptide alone. The CTL were washed andassayed
on R1.1-Ld target cells that had been induced overnight with 10-4 M
MCMV peptide. (0) BALB/c anti-MCMV peptide; (0) BALB/c anti-
MCMV peptide-fed P815; (A) BALB/c anti-MCMVpeptide + 1:500 anti-
CD8 ascites during assay; (p) BALB/c alone. (B) MCMV peptidedose-
response for peptide-induced primary CTL. Either 5 x 106 (FI) or 7.5
x 106 (A) responding BALB/c spleen cells were cultured for 5 d in the
presence of variousconcentrations of MCMV peptide. Target cells were
R1.1-Ld induced overnight with 10-4 MCMV peptide before the assay.
Shaded symbols (A, /) represent CTL assayedin the presence of 1:500
anti-CDS ascites.
element (14). The cells were washed and used as stimulators
for BALB/c responder spleen cells. As seen in Fig. 1A, CTL
were generated that were capable of lysing peptide-induced
(10-4 M, overnight) R11-Ld target cells but not R11-Ld
without peptidetreatment (not shown). In addition, including
peptide alone (3 x 10 -5 M) with the BALB/c spleen cell
cultures was even more efficient at generating peptide-specific
CTL. This is independent of the responder cell concentra-
tions tested, which arein therange normally used forin vitro
primary CTL cultures (Fig. 1 B). However, there is a direct
correlation between the amount of peptiderequired to generate
peptide-specific CTL in vitro (Fig. 1 B) and that required
to induce increased expression of Ld (10). Even at relatively
low peptide concentrations and low responder cell concen-
trations, peptide-specific CTL were obtained. In addition,
this peptide-specific primary CTL response was found to be
strongly CD8 dependent (Fig. 1).
MCMVspecific primaryCTL, obtained by direct addition
of peptide to the cultures, were tested on a panel of R1.1
transfectant cell lines, expressing the class I molecules, Ld,
Dd, L9, or D9, that were cultured overnight with 10-4
MCMV peptide. As shown in Fig. 2 A, only cells bearing
Ld were lysed, confirming that these CTL are indeed Ld re-
stricted. In addition, primary, peptide-specific CTL were ob-
tained using a different peptide, turn -, also previously
shown to use Ld as the restricting element (13). The CTL
generated to the turn - peptide lysed only targets bearing Ld
plus turn - , and CTL generated to MCMV peptide lysed
only targets bearing Ld plus MCMV peptide, demonstrating40
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￿
Peptide-induced primary CTL are Ld restricted and peptide
specific. (A) BALB/c anti-MCMV primary CTL were assayed on a panel
of R1.1 target cells transfected with the Ld (O), Dd (0), Lq (A), or D9
(0) gene. The target cells were cultured overnight with 10-4 M MCMV
peptide and washed before the assay. (B and C) Lysis of R1.1-Ld cultured
overnight with 10-4 M MCMV peptide (B) or 10-4 M turn - peptide
(C) by BALB/c anti-MCMV primary CTL (O) or BALB/c anti-tum -
primary CTL (A).
the peptide specificity of primary CTL generated with pep-
tide alone (Fig. 2, B and C) .
Recognition by Peptide-induced Primary CTL Is Accomplished
at Low Target CellDeterminant Density. For the experiments
described above, the target cells were treated overnight with
peptide to induce maximum levels of expression of the
Ld/peptide complex. The peptide-specific CTL were gener-
ated with high doses of peptide (10-4 M) and thus resulted
from stimulation with cells expressing high determinant den-
sity. Since these CTL were also strongly CD8 dependent,
we wanted to determine if these primary CTL would then
only recognize target cells expressing high determinant den-
sity. We treated target cells with MCMV or turn - peptide
under conditions that give maximum induction of La ex-
pression (10 -4 M, overnight), low but detectable induction
of La expression (10 -4 M, 1 h), or no detectable induction
of La expression (10 -5 to 10 -10 M, 1 h) . These lower doses
have been shown to result in lysis by specific clones derived
from MCMVinfected mice (11) and mice immunized with
P911, the cell line expressing the turn - determinant en-
dogenously (13) . As seen in Table 1, near maximum levels
of lysis are obtained when target cells are treated with pep-
tide for only 1 h as compared with overnight incubation.
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Primary CTL were induced with peptide at 10-4 M for 5 d.
t An E/T ratio of 80:1 is shown. Additional ratios were run at each point with similar results.
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P911
Figure 3.
￿
Surface expression ofLd on peptide-induced and -uninduced
cell lines that express endogenous, Ld-restricted antigenic determinants.
P911 was cultured overnight with or without 10-4 M turn- peptide, and
L/iel/Ld was cultured overnight with or without 10-4 M MCMV pep-
tide. Ld expression was measured with mAbs 30-5-7 and 28-14-8, and
FITC-conjugated, F(ab')2 goat anti-mouse IgG, Fc-specific antibody was
used as developing reagent. Background (Bkgd) represents fluorescence
emitted from cells incubated with the developing reagent alone.
At 10 -4 M for 1 h, 90-95% of the lysis obtained at 10-4 M
overnight is seen. When target cells are treated with peptide
concentrations as low as 10 -10 M, 70-80% of the lysis is
still obtained. These data demonstrate that a significant propor-
tion ofthe peptide-induced primary CTL are capable oflysing
target cells expressing low determinant density. These data
also demonstrate a difference in the determinant density re-
quirements for sensitization vs. effector cell function. Although
a high determinant density was required to induce primary
CTL in vitro, these same CTL were capable of recognizing
target cells with relatively low determinant density.
Peptide-induced Primary CTL Can Lyse Target Cells En-
dogenously Expressing Antigen. In previous studies by Car-
bone et al. (7), CTL generated in vitro with peptide were
unable to lyse targets expressing the determinant endogenously.
The most plausible explanation for this observation was that
the endogenous determinant was expressed at too low a den-
Table 1 . Effect of Target Cell Determinant
10-4 M
Density on Recognition by
Percent specific 5'Cr
10-4 M
Primary
release from
10-1 M
Peptide-induced CTL
P815t treated with
10-6 M
peptide at:
10-8 M 10 -10 M
Exp. Peptide' (overnight) (1 h) (1 h) (1 h) (1 h) (1 h)
1 MCMV 80 76 66 67 ND ND
2 MCMV 53 ND ND 45 35 36
3 turn- 87 79 ND 79 66 67m
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Figure4.
￿
Peptide-induced primaryCTL arecapableoflysing target cells
expressing endogenous determinants. (A) BALB/c spleen cells cultured
for 5 d with 10-4 M turn - peptide were assayed for lysis of P815 (!]),
P911 (O), or P815 + turn- peptide (A). (B) BALB/c spleen cells cul-
tured for 5 d with 10 -4 M MCMV peptide were assayed for lysis of LLd
(p), L/iel/Ld (O), or LLd + MCMV peptide (A).
0
a
sity. Since Ld-restricted, peptide-specific CTL were more
readily obtained during in vitro primary culture, in compar-
ison with previous attempts, and because they could lyse targets
treated with a low concentration of peptide, we wanted to
determine if they were capable of lysing target cells en-
dogenously expressing the turn- or MCMV antigens. The
target cells used for this analysis are P911, a mutant derived
from P815 that endogenously expresses the turn - antigen,
and L/iel/Ld, an L cell transfected with both the Ld gene
and the gene coding for the immediate early protein (pp89)
of MCMV that endogenously expresses the MCMV antigen.
Both of these cell lines have been previously shown to be
recognized by Ld-restricted CTL clones generated, respec-
tively, by in vivo immunization with P911 or MCMV viral
infection (12, 13, 20). The peptides used in our studies have
been shown by Lurquin et al. (turn -) (13) and Reddehase
et al. (MCMV) (11) to serve as the optimum target deter-
minant for recognition by these CTL clones. The surface
expression of Ld on P911 is lower than Kd and Dd (not
shown), just as it is on the parent line, P815 (10). As shown
in Fig. 3, surface Ld expression is induced when P911 is cul-
tured overnight with 10 -4 M turn- peptide and also when
L/iel/Ld is cultured overnight with 10 -4 M MCMV pep-
tide. The level of induction of Ld is comparable with that
obtained with turn - peptide-fed P815 and MCMV peptide-
fed LLd, as previously reported (10). This demonstrates that
the endogenous turn- or MCMV peptide is not produced
in amounts sufficient to significantly increase the expression
of Ld. These cell lines were used as targets for primary, Ld-
restricted, peptide-specific CTL . P815 and LLd incubated
with exogenous peptide for 1 h were used as control targets.
Several interesting points can be made from the results of
this analysis shown in Fig. 4. First, in contrast to the earlier
reports (7, 8), peptide-induced, Ld-restricted primary CTL
are capable of lysing target cells that express antigen en-
dogenously. Second, the lysis is weak on P911 in comparison
with peptide-fed P815, suggesting that P911 cells express the
determinant at a density much lowerthan obtained with pep-
tide feeding. In addition, turn- peptide-fed P911 were lysed
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￿
Re-stimulation of peptide-induced primary CTL with lower
doses of peptide. (A) Cells obtained from the MCMV peptide-induced
primary CTL culture shown in Fig. 2 A were restimulated for one addi-
tional week at 3 x 106 cells/ml with 100, 50, and 25 AM MCMV pep-
tide and assayed against 10-4 M R1.1-Ld + MCMV peptide, overnight.
(B) The cells from the 25- and 50-uM peptide groups in A were pooled
and restimulated for an additional week at 2 x 105/ml in the presence
of RCAS and irradiated BALB/c spleen cells (see Materials and Methods)
with 25, 12, 6, and 3 AM MCMV peptide and assayed against 10-4 M
Rl.l-Ld + MCMV peptide, overnight. 25 AM MCMV stimulated CTL
plus 1:500 anti-CD8 ascites during assay (").
at levels equivalent to turn peptide-fed P815 (not shown) ex-
cluding differences in target cell lysability. However, in the
case of L/iel/Ld, peptide feeding LLd target cells (or
L/iel/Ld, not shown) results in a modest increase in lysis
compared with L/iel/Ld, suggesting that L/iel/Ld may ex-
press endogenous MCMV determinants at levels greater than
P911 expresses endogenous turn - determinants. This is con-
sistent with L/iel/Ld being a transfected cell line with mul-
tiplegene copies, thus leading to overproduction of the gene
products. Also, since L cells are poor targets for primary CTL,
possibly due to low basal expression of surface intercellular
adhesion molecule 1 (21), additional factors may contribute
to lysability differences. We therefore wanted to examine the
effect ofdeterminant density on CTL recognition more thor-
oughly. Because the targets expressing endogenous antigen
are lysed weakly by peptide-induced primary CTL, and be-
cause L cells are poor targets for primary CTL, we decided
to generate CTL lines and clones that would be useful for
this analysis, and to rely primarily on P911 and peptide-fed
P815 as targets.
Analysis ofDeterminant Density Requirements UsingPeptide-
induced CTL Clones. CTL lines and clones were established
from MCMV peptide and turn- peptide-induced primary
CTL cultures usinglower doses of peptide than required for
the generation of in vitro primary peptide-specific CTL. As
shown in Fig. 5, highly efficient MCMVspecific CTL were
obtained after successive restimulation with peptide. A pos-
sible explanation for the inverse correlation observed between
the response of the CTL and the peptide concentration used
to restimulate (Fig. 5 A) is that the responding cell concen-
tration was sufficiently high to result in competition for
nutrients. These CTL maintained their CD8 dependency for
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Figure 6.
￿
Correlation between lysis of P911 and the amount of turn
peptide required to sensitize P815 for lysis by turn --specific CTL clones.
The closed symbols represent lysis of P911 by clones 5.40 (A), 7E5 ("),
and 7H5 ("). The open symbols represent lysis of P815 treated for 1 h
with various concentrations of turn - peptide by the same clones, 5.40
(p), 7E5 (O), and 7115 (A). The E/T ratio was 10:1 for 5.40 and 7.5:1
for 7E5 and 7115.
several additional months in culture at the lowest dose used
(3 p.M). Several additional MCMV and turn- -specific lines
and clones were obtained using 6-10 AM peptide for weekly
restimulation. These lines and clones possessed various but
stable CD8 dependencies, suggesting that the amount of pep-
tide used did not select for high or low affinity CTL.
When the turn- peptide was used, the majority of clones
obtained were able to lyse P911 to various degrees. Some of
the clones lysed P911 and peptide-fed P815 equally well,
whereas other clones displayed better lysis of peptide-fed
targets. For the data shown in Fig. 6, three representative
clones were selected based on the differences in their ability
to lyse P911 as compared with turn - peptide-fed P815.
When the turn- peptide used to sensitize targets was titered
from 10 -4 to 10-13 M, a direct correlation was observed be-
tween the level of lysis on P911 and the amount of peptide
required to sensitize P815. Clone 5.4, which does not lyse
P911 at all, even at higher E/T ratios than shown here, re-
quires a high concentration of peptide to obtain maximum
lysis of P815. Clone 7115, which shows the strongest lysis
ofP911, requires the least amount ofpeptide to sensitize P815,
and clone 7E5 has a phenotype intermediate between the two.
These data demonstrate an inverse correlation between the
amount of exogenous peptide required to sensitize the target
cell for recognition by a given clone and the degree to which
that clone is able to lyse the target expressing the antigen
endogenously. In addition, peptide alone can be used to in-
duce specific CTL with vastly different antigen density re-
quirements.
CD8 Dependency of Peptide-induced CTL Clones Correlates
with Determinant DensityRequirement. It has been suggested
that the CD8 dependency of CTL correlates directly with
the target cell antigen density required for recognition and
inversely with the affinity of the CTL (22). We have previ-
ously defined CD8 dependency based on the ability of a high
concentration ofmAb to CD8 (1:500 ascites) to block recog-
nition of target cells expressing high determinant density.
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￿
Comparison ofCD8 dependency ofclones 7E5 (A) and 7115
(B) tested on P911 and turn- peptide-fed P815. Lysis of P911 (O) and
10-4 M P815 + turn - peptide, for 1 h (0). Closed symbols (", A) rep-
resent lysis in the presence of 1:500 anti-CD8 ascites during the assay.
We wanted to determine the relationship between the target
cell determinant density requirement and the CD8 depen-
dency for peptide-induced CTL clones. The clones described
above are ideal for this analysis because they vary greatly in
the minimum amount of peptide required to sensitize P815
for recognition and therefore also in their ability to lyse P911.
Antibody to CD8 strongly inhibited lysis of P911 by all
of the clones tested (18 total), two of which are shown in
Fig. 7. However, when anti-CD8 was used to inhibit lysis
of peptide-fed P815, one of the clones, 7E5, was completely
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￿
Correlation between CD8 dependency of CTL clones and
target cell determinant density. Turn --specific, C138-dependent (7E5) and
CD8-independent (7115); and MCMVspecific, CD8-dependent (2.9C1)
and CD8-independent (6.15A8) CTL clones were assayed against P815
treated for 1 h with various concentrations of either turn- or MCMV
peptide. Several dilutions of anti-CD8 antibody were included during the
4-h assay for each target cell peptide concentration. 7E5 and 7115 were
assayed against turn--treated P815 at an E/T ratio of 7.5:1, and 2.9C1
and 6.15A8 were assayed against MCMVtreated P815 at an E/T ratio of
2:1. All of the clones showed no lysis of P815 without peptide.Figure 9.
￿
Surface expression ofCD8 by various CTL clones. Cells were
incubated with anti-CD8 culture supernatant and developed with an FITC-
conjugated, goat anti-rat IgG. Mean fluorescence above background was
122 for 7E5, 127 for 7H5, 129 for 2.9C1, and 111 for 6.15A8.
inhibited, whereas the other, 7H5, was not inhibited at all.
The activity of clone 5.4, which only lysespeptide-fed P815,
was also strongly inhibited by anti-CD8 (not shown).
Therefore, clone 7H5, which required the least amount
of exogenous peptide and lysed P911 at levels nearly equiva-
lent to lysis of peptide-fed P815, was the least dependent on
CD8. Since this clone was CD8 dependent when tested on
P911, it seemed reasonable to assume that reducing the amount
of exogenous peptide added to the target cells would alter
the CD8 dependency of the clone. The data shown in Fig.
8 indicate that this is indeed the case. CD8-dependent and
CD8-independent turn - - and MCMVspecific CTL clones
were compared over a broad range of target cell determinant
densities by titering the amount of peptide used to sensitize
the target cells. Anti-C138 antibody was titered at each pep-
tide concentration. Those clones, which require a higher an-
tigen density for optimum lysis (7E5 and 2.9C1), are depen-
dent on CD8 at all peptide concentrations tested. The clones
that require low target antigen density (7H5 and 6.15A8)
function independently of CD8 at higher peptide concentra-
tions. However, when the antigen density decreases to a
threshold level (which may be different for each clone), the
CD8-independent clones become increasingly dependent on
CD8. Importantly, there are peptide concentrations that re-
sult in maximum or near maximum levels of lysis of the target
cell (10- e to 10-1° M in Fig. 8), yet all of the clones tested
are CD8 dependent. These data demonstrate an inverse corre-
lation between the antigen density of a target cell and the
requirement for CD8 by the effector cell. Also, CD8 depen-
dency is not absolute for a given clone since the CD8 depen-
dency can change as the antigen density changes.
The CTL clones shown in Fig. 8 were analyzed for surface
expression of the CD8 receptor and were all found to express
CD8 at high levels. Although there were slight differences
between clones, there was no correlation between the level
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of surface expression of CD8 and the sensitivity to inhibi-
tion by antibody to CD8 (Fig. 9).
Discussion
In this report we demonstrate, quantitatively, the effect
of determinant density on the priming of, recognition by,
and CD8 dependency of Ld-restricted, peptide-specific CTL.
A significant finding reported here is that MHC-restricted,
peptide-specific CTL are easily generated in vitro with pep-
tide alone, and that these CTL are capable of lysing target
cells expressing endogenous antigen. The concentrations of
peptide required to induce detectable activity during primary
in vitro culture are the same as those required to increase
the expression of Ld on cell lines such as P815 and LLd.
Since overnight culture of these cell lines with specific pep-
tide ligands results in a 2.5-4-fold increase in the level of ex-
pression of Ld, 60-75% of the surface Ld molecules contain
the fed peptide, resulting in a high density of the specific
MHC-peptide complex. It is likely that it is this increased
determinant density that accounts for the ability to generate
primary Ld-restricted CTL in vitro with peptide. Indeed, the
strength of the response correlatesprecisely with the amount
of peptide and therefore the level of induction of Ld.
Although high peptide concentrations are required for in
vitro stimulation, target cell sensitization is accomplished with
much lower doses of peptide. Initially, target cells were sen-
sitized with a peptide concentration known to induce max-
imum expression of Ld to ensure optimum lysis by primary
CTL. However, these primary, peptide-induced CTL can
efficiently lyse target cellssensitized with peptide under con-
ditions known to result in little or no detectable increase in
Ld surface expression, demonstrating a significant difference
in the determinant density requirement for in vitro priming
ofprecursor CTL as compared with effector cell recognition.
Indeed, these peptide-induced primary CTL are capable of
lysing target cells expressing the determinant endogenously.
In. a report by Carbone et al. (7), cells expressing endoge-
nous determinants were not lysed by primary CTL gener-
ated with either OVA peptides or an influenza peptide, even
after long-term culture. The authors argued that the assumed
higher surface density during priming in their system would
only allow T cells with low receptor affinity to respond, thus
accounting for the inability to lyse cells expressing endoge-
nous determinants. In one case, restimulation of a long-term
influenza peptide-specific CTL line with virus-infected cells
allowed CTL to develop that were capable oflysing endoge-
nous targets. This suggested that higher affinity clones were
present in very low numbers. The authors also recognized
the possibility that the OVA peptide they used for in vitro
priming was not presented as an endogenous determinant
by the target cell. Our system has the advantage that the pep-
tides selected were previously shown to include a major anti-
genic determinant for MCMVspecific CTL generated in vivo
(23) and the only antigenic determinant for P91A - (turn- )-
specific CTL generated in vivo (13). Although the optimal
size of the synthetic peptide in vitro may not be identicalto the size of the processed fragments, the peptide-induced
CTL can nonetheless recognize the processed fragments on
both P911 and L/iel/Ld. Analysis of the determinant den-
sity requirements of several clonal populations of turn - pep-
tide-specific CTL demonstrates that a correlation exists be-
tween the amount ofpeptide required to sensitize target cells
for recognition and the ability to lyse P911. This suggests
that the poor recognition of P911 by primary CTL results
from low determinant density. In agreement with this quan-
titative interpretation, Chen et al. (24) recently reported that
an HLA-DR11.1-restricted, HLAB7 peptide-specific CTL
line was capable of lysing targets homozygous but not het-
erozygous for both B7 and DR11.1.
In previous reports, we demonstrated that the CD8/class
I interaction is required for priming responses to alloantigens
and that CD8-independent CTL cannot develop in the ab-
sence of a CD8-dependent response (25, 26). In the studies
reported here, when the level of the Ld/peptide complex is
increased to approximate the level of expression of alloan-
tigens, a peptide-specific in vitro primary response is obtained.
This primary response is strongly CD8 dependent, as is the
in vitro primary response to alloantigens, emphasizing the
significance of the participation of CD8 for priming both
allogeneic and MHC-restricted responses. From the data
presented here, we would conclude that the CD8/class I in-
teraction is achieved more efficiently in the presence ofa high
determinant density on the stimulator cells.
We (26) and others (27) demonstrated that the TCR and
the CD8 molecule on the CTL must interact with the same
class I molecule. Therefore, titering the peptide during target
cell sensitization results in the simultaneous titration of both
the TCR ligand and the CD8 ligand. Using this approach,
we were able to dramatically and quantitatively demonstrate
an inverse correlation between determinant density on the
target cell and the CD8 dependency of peptide-specific CTL
clones. More antibody was necessary to block target cell rec-
ognition by clones that required lower determinant density
on the target cell. For example, all of the turn --specific
clones isolated required some participation of CD8 to lyse
P911, even the highest affinity clones isolated, such as 7H5.
However, more antibody was required to block the recogni-
tion of P911 by 7H5 than was required to block recognition
of P911 by 7115. In addition, CD8 dependency is indepen-
dent of the level of expression of CD8 by the CTL, since
the clones analyzed express CD8 at comparably high levels.
What is clearly and quantitatively demonstrated here is
that the degree to which a given clone is dependent on CD8
is a function of the determinant density of the target cell.
Therefore, CD8 dependency is not absolute for a given clone,
nor are there two distinct classes of CTL: CD8 dependent
and CD8 independent. CD8 dependency is generally defined
by the ability of saturating concentrations of antibody to CD8
to block CTL recognition of targets with fairly high deter-
minant density. This is convenient for relative comparisons
between populations of CTL, since dramatic differences in
CD8 dependency do exist among clones. However, the
predicted CD8 dependency defined by in vitro analysis may
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not reflect the actual CD8 dependency under in vivo condi-
tions. In vivo, a CTL is more likely to encounter target de-
terminants expressed at low density and will therefore re-
quire the participation ofCD8 to achieve effective interaction.
This effect of determinant density has important biological
consequences. For example, it has been proposed that tumor-
specific peptides may bind class I molecules leading to de-
struction of the tumor cellsby host CTL (28). Indeed, tumor
cells that downregulate class I expression avoid immune rec-
ognition (29-33), and when converted to a high class I an-
tigen expressing phenotype through gene transfer, become
less malignant when injected into the host (34-37). This im-
plies that the tumor cells with higher determinant density
are now recognized by the immune system.
A correlation between determinant density and CD8 de-
pendency has been suggested by other investigators. In one
case, papain treatment of target cells reduces H-2 density and
increases susceptibility to blocking of CTL killing by anti-
CD8 antibody (38). However, enzyme treatment could affect
other surface molecules in an unknown manner. Others have
used class 1-bearing artificial membranes to stimulate cells
from primed animals (39). Although their data suggest a
reciprocal relationship between antigen density and suscepti-
bility to blocking with anti-CD8, in agreement with us and
others (22), they conclude that the antigen density require-
ments are identical for activation of precursor CTL and for
effector function. However, their conclusion is based on results
with in vitro secondary responses. In another study, the ability
of CTL clones to lyse target cells expressing low classI versus
the same target cells expressing high class I after IFN-'y in-
duction was correlated with inhibition by anti-CD8 antibody
(22). These authors concluded that CTL clones that are less
dependent on antigen density are more resistant to inhibi-
tion by anti-CD8.
The advantage of our system is that, using peptide alone,
we were able to generate Ld-restricted peptide-specific pri-
mary CTL and CTL clones with vastly different determinant
density requirements. By titering the amount of target cell
peptide over a broad range of peptide concentrations, we were
able to quantitatively correlate CD8 dependency with deter-
minant density. A significant observation is that even a very
high affinity clone, one that appears to be CD8 independent,
requires the participation of CD8 when faced with a low
determinant density expressing target cell. Since low deter-
minant density is likely to be encountered in vivo, the partic-
ipation of CD8 during effector function may be more
significant than estimated by in vitro analysis.
There is, however, one intriguing aspect of the Ld-re-
stricted CTL response reported here that is not easily explained
in the context ofthe earlier report by Carbone et al. (7) sup-
porting a determinant density model. Their model would
predict that the extraordinary accessibility of the Ld ligand-
binding site to peptide would result in stimulators with a
high determinant density capable of preferentially eliciting
CTL with lower affinities. However, we report here that
peptide-induced, Ld-restricted CTL can lyse target cells that
express low determinant density, including those that expressthe determinant endogenously. This property of the Ld pep-
tide response appears to be unique, thus distinguishing it from
previous reports in which peptide-induced CTL could not
lyse endogenous expressors or in some cases showed broad
MHC crossreactivity (7). There are examples of peptide ei-
ther coupled to a known mitogenic lipid moiety (8) or in-
corporated into the adjuvant glycoside Quil A (9) that in-
duced CTL in vivo capable oflysing endogenous targets, even
though noncoupled peptide failed to do so. In addition, an
HLA classII-restricted CTL line specific for an endogenous
HLA class I peptidewasobtained only after long-term stim-
ulation with peptide (24). It is therefore intriguing why Ld
ligands can so easily stimulate CTL capable of recognizing
targets with a low determinant density. Perhaps this is a reflec-
tion of the TCR repertoire to Ld/peptide. Previous reports
have demonstrated that Ld molecules clearly have a unique
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